WHO ICTRP trial
Evaluation of vitamin D effect on diabetic macular edema
IRCT20200407046978N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20200407046978N1 |
|---|---|
| Public title | Evaluation of vitamin D effect on diabetic macular edema |
| Scientific title | Effect of intravitreal bevacizumab (Avastin®) plus vitamin D supplementation on diabetic macular edema in vitamin D deficient patients |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | diabetic macular edema. Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema;E08.311 |
| Interventions | Intervention 1: Control group: Patients with insufficient/ deficient leveLs of vitamin D and diabetic macular edema; Intervention: IVB. Intervention 2: Intervention group: Patients with insufficient/deficient levels of vitamin D and… |
| Registration date | Apr 11, 2020 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: